MediWound Ltd. (MDWD) vs Satellos Bioscience Inc. (MSLE)

MediWound Ltd. and Satellos Bioscience Inc. are both Biotechnology companies. MediWound Ltd. and Satellos Bioscience Inc. are of similar size ($184.8M and $178.6M). Satellos Bioscience Inc. has the higher net margin (0.00% vs −170.1%) and the higher return on invested capital (0.00% vs −6,551.8%). Across the 11 metrics below, Satellos Bioscience Inc. leads on 8 and MediWound Ltd. on 3.

Valuation

Metric MDWD MSLE Biotechnology median
P/E n/m n/m 7.88
P/S 15.04 n/m 11.47
P/B 5.01 3.03 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 12.14 n/m 10.73
Earnings yield (11.55%) (22.07%) (28.84%)
Free cash flow yield (16.01%) (16.01%) (23.03%)

Profitability

Metric MDWD MSLE Biotechnology median
Gross margin 15.46% — 65.16%
Operating margin (267.75%) 0.00% 0.00%
Net margin (170.10%) 0.00% 0.00%
Free cash flow margin (240.47%) 0.00% 0.00%
Return on equity (75.42%) (70.45%) (57.72%)
Return on assets (29.06%) (64.76%) (49.22%)
Return on invested capital (6,551.77%) 0.00% 0.00%

Growth

Metric MDWD MSLE Biotechnology median
Revenue growth (TTM) (40.26%) — 5.64%
EPS growth (last fiscal year) 30.69% 21.20% —
Revenue growth, 5-year CAGR (4.87%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDWD MSLE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.32 11.22 4.73
Net debt to EBITDA 2.27 1.05 0.96

Dividend

Metric MDWD MSLE Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric MDWD MSLE Biotechnology median
Market cap 178.55m 184.83m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack